Position in ALNY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$28,685,436
+$9,383,505 QoQ
Shares Held
86,697
+78.6% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $89,889,169 across 7 Biotechnology names. ALNY ranks #1 (31.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
86,697 | $28,685,436 | |
| 2 | INCY |
Incyte Corp
|
259,048 | $24,381,597 | |
| 3 | INSM |
INSMED Inc
|
77,970 | $12,749,654 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,903 | $10,673,645 | |
| 5 | RPRX |
Royalty Pharma plc
|
177,500 | $8,514,675 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,232 | $3,269,812 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
16,600 | $1,614,350 |
All Filings in ALNY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,685,436 | 86,697 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $19,301,931 | 48,540 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,439,200 | 20,700 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,250,021 | 6,900 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $4,536,336 | 16,800 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,565,149 | 27,900 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,492,881 | 12,700 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $753,300 | 3,100 | Shares | Sole | 2024-08-07 | |
| 2023-12-31 | $6,795,055 | 35,500 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $6,109,950 | 34,500 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $7,692,570 | 40,500 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,054,464 | 45,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,213,340 | 55,600 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,727,776 | 48,600 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,140,285 | 42,100 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $4,816,072 | 28,400 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $3,757,319 | 19,900 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,949,648 | 17,400 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,259,040 | 16,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,404,445 | 18,500 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,067,520 | 14,200 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,642,991 | 38,100 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $3,744,440 | 34,400 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||